National Medical Care Company (TADAWUL:4005)
122.00
-0.30 (-0.25%)
Aug 13, 2026, 3:19 PM AST
TADAWUL:4005 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 299.59 | 318.47 | 294.7 | 240.93 | 170.07 | 164.4 |
Depreciation & Amortization | 114.6 | 109.07 | 82.49 | 51.54 | 41.9 | 50.16 |
Other Amortization | 1.59 | 1.59 | 1.47 | 3.39 | 3.78 | - |
Loss (Gain) From Sale of Assets | 0.17 | -0.16 | -0.06 | -0.01 | -0.01 | -0.15 |
Stock-Based Compensation | 4.31 | 3 | - | - | - | - |
Provision & Write-off of Bad Debts | 18.4 | 17.77 | 32.72 | -0.37 | 4.95 | 9 |
Other Operating Activities | 13.98 | 18.82 | -69.53 | 13.71 | 19.65 | -11.24 |
Change in Accounts Receivable | -457.95 | -298.06 | -70.71 | 192.88 | -41.06 | -142.78 |
Change in Inventory | -6.03 | -6.65 | -0.72 | -7.67 | 3.2 | -0.01 |
Change in Accounts Payable | -35.24 | -9.88 | -25.7 | -27.67 | 14.37 | 24.43 |
Operating Cash Flow | -46.56 | 153.97 | 244.66 | 466.74 | 216.85 | 93.8 |
Operating Cash Flow Growth | - | -37.07% | -47.58% | 115.23% | 131.18% | -12.10% |
Capital Expenditures | -237 | -127.17 | -108.02 | -54.01 | -31.02 | -32.19 |
Sale of Property, Plant & Equipment | 0.28 | 0.16 | 0.09 | 0.15 | 0.02 | 0.2 |
Cash Acquisitions | - | - | -23.48 | -185.52 | - | - |
Sale (Purchase) of Intangibles | -2.3 | -3.86 | -1.54 | -0.56 | -0.66 | -5.23 |
Sale (Purchase) of Real Estate | - | - | -141.68 | - | -180.15 | -3.5 |
Investment in Securities | - | 252.26 | 82.08 | -385 | - | - |
Investing Cash Flow | -239.03 | 121.39 | -192.56 | -624.94 | -211.81 | -40.72 |
Long-Term Debt Issued | - | 136.26 | 37.93 | 190.69 | - | - |
Total Debt Issued | 421.21 | 136.26 | 37.93 | 190.69 | - | - |
Long-Term Debt Repaid | - | -106.12 | -11.07 | -8.18 | -5.94 | -5.94 |
Total Debt Repaid | -235.96 | -106.12 | -11.07 | -8.18 | -5.94 | -5.94 |
Net Debt Issued (Repaid) | 185.25 | 30.14 | 26.87 | 182.51 | -5.94 | -5.94 |
Repurchase of Common Stock | - | - | -34.11 | - | - | - |
Common Dividends Paid | -134.07 | -89.38 | -89.7 | -44.85 | -44.85 | -44.85 |
Financing Cash Flow | 51.18 | -59.24 | -96.95 | 137.66 | -50.79 | -50.79 |
Net Cash Flow | -234.41 | 216.12 | -44.84 | -20.54 | -45.75 | 2.29 |
Free Cash Flow | -283.57 | 26.8 | 136.63 | 412.73 | 185.83 | 61.61 |
Free Cash Flow Growth | - | -80.39% | -66.90% | 122.10% | 201.60% | -33.88% |
Free Cash Flow Margin | -17.07% | 1.68% | 10.56% | 38.15% | 20.24% | 7.29% |
Free Cash Flow Per Share | -6.34 | 0.60 | 3.05 | 9.20 | 4.14 | 1.37 |
Levered Free Cash Flow | -401.2 | -101.77 | -19.94 | 347.12 | 135.85 | 22.24 |
Unlevered Free Cash Flow | -383.32 | -84.92 | -5.73 | 349.31 | 135.85 | 22.24 |
Cash Interest Paid | 33.83 | 29.32 | 22.36 | 1.42 | - | - |
Change in Working Capital | -499.22 | -314.59 | -97.13 | 157.54 | -23.49 | -118.36 |